Composite 6.62 / 10, weighted per the Constitutional Weight Schedule.
Below the 700 bar, Author's Verdict: not supported.
Lands in the Sound band at credit 678, below the 700 support line, Author's Verdict: not supported. (See section 7 for the full reasoning.)
No military service record. Pre-Congress career: EPA economist, environmental lawyer (~15 years), San Diego City Council 2000-2008 (council president 2006-2008), San Diego Unified Port District commissioner and chairman 2009-2012. Civilian public service is context, not a score.
The 14 measures
Each measure is scored 0–10 against an anchored example, with a cited source. Hover/expand why? for the reasoning.
| # | Measure | Score | Why |
|---|---|---|---|
| M01 | Duty to Constitution & Rule of Law | 6 | why?No documented subversion of constitutional process. As a Democrat seated in 2013 he is not on the Texas v. Pennsylvania amicus (126 House Republicans, Dec 2020) and has no fake-elector or election-overturn conduct on record. Held at upper-middle rather than higher because the affirmative defense-of-the-oath-at-personal-cost record (the bar McCain clears) is not documented here; he honors process without a signature stand for it against his own side. [source] |
| M02 | Party Over Country | 8 | why?Genuine cross-aisle posture: Problem Solvers Caucus member, New Democrat Coalition vice-chair, and a 2016 analysis ranked him among House members most likely to vote against his own party. Pursues bipartisan climate and energy legislation. Country-and-institution-over-tribe is a real, documented pattern, not rhetoric. [source] |
| M03 | Persons of Equal Worth | 7 | why?No documented anti-belonging conduct, no slurs, no casting of constituents or opponents as illegitimate. Standard upper-middle for a clean record without a high-mark affirmative defense-of-an-opponent's-personhood anchor. [source] |
| M04 | Weaponization of Justice | 7 | why?No documented weaponization of state power against rivals or critics. No criterion-class conduct on record. [source] |
| M05 | Incitement / Anti-Belonging | 7 | why?Measured, technocratic public rhetoric consistent with his moderate brand; no documented dehumanizing or inciting pattern. Upper-middle on restraint without a standout high-mark moment. [source] |
| M06 | Fiduciary Conduct | 5 | why?Two weighed appearance-concerns, neither a finding. Pre-Congress: as a San Diego councilmember during the city pension underfunding, the Kroll Report called the council 'negligent' but the SEC cleared the members of fraud (resolved, no charge against him, weighed as appearance only). In office: pharmaceutical PACs are his top-two career donor industry and he led 2021 opposition to Medicare drug-price negotiation, a donor-aligned appearance-concern. Net middle: legal, no sanction, but a real fiduciary-optics drag. [source] |
| M07 | Duty to Call Out | 6 | why?Has broken with his own party at cost, voting against fellow Democrats and publicly prizing an 'independent record,' which meets the active call-out duty to some degree. Held at middle-plus rather than higher because the most prominent same-side break (blocking the 2021 drug-price bill) coincided with heavy industry support, blunting the 'at cost' purity the higher bar requires. [source] |
| M08 | The Discretion Test | 6 | why?No documented abuse of discretionary advantage or self-serving use of position privileges. Standard middle-plus for an unremarkable discretion record absent a documented self-sacrifice anchor. [source] |
| M09 | The No-Camera Test | 7 | why?No documented private/public contempt gap or off-camera hypocrisy. Consistent moderate posture on and off the record. [source] |
| M10 | Constituent-vs-Donor Vote | 5 | why?The clearest documented drag. By mid-2022 his pharmaceutical-industry contributions ($88,550 that cycle; $860k+ career) led all House members, and he was a decisive vote against allowing broad Medicare drug-price negotiation. Scored as conduct, the donor-alignment appearance-concern, not the policy merits, placing constituent-vs-donor fidelity squarely at the middle. [source] |
| M11 | Net-Worth Trajectory | 7 | why?Scores office-attributable enrichment only. He is an active equity trader, but no documented STOCK Act enforcement, self-dealing finding, family-payment scheme, or office-information trade is on record (the 2021 NPR/CLC STOCK Act complaint named other members, not Peters). Raw wealth is not penalized. Held below the top tier because active individual trading by a sitting member committee-adjacent to traded sectors is a standing structural appearance-risk, not a clean abstention. [source] |
| M12 | Floor Decorum | 7 | why?Maintains institutional decorum and regular-order posture; no documented stunts, contempt of process, or spectacle-over-substance pattern. Solid institutional respect. [source] |
| M13 | Lying & Misleading | 7 | why?No sustained documented-falsehood pattern; statements track a coherent moderate record. No big-lie or disinformation conduct on record. [source] |
| M14 | Knowledge Depth | 7 | why?Substantive command of energy, climate, and health policy as a former environmental lawyer and Energy & Commerce member; chairs the New Democrat Coalition climate working group. Substance over talking points, with the caveat that the depth on drug pricing is entangled with donor interests rather than purely analytic. [source] |
Why not higher, the points withheld
The standard is the seat; the ceiling is a perfect 10. Every withheld point traces to documented conduct, weighed where the measures and attributes say it belongs, shown openly here, the same way the earned points are.
| Where | Documented conduct | Mitigation weighed |
|---|---|---|
| M10 | Led all House members in pharmaceutical-industry contributions in the 2022 cycle ($88,550; $860k+ career) and cast a decisive 2021 vote against broad Medicare drug-price negotiation ↳ constituent-vs-donor alignment (appearance-concern, not a finding) | Legal contributions, disclosed; scored as donor-alignment optics, not as self-dealing or a policy judgment |
| M06 | San Diego pension underfunding (Kroll Report 2006 called the council 'negligent'; SEC cleared members of fraud) + in-office pharma-donor-aligned drug-pricing posture ↳ Fiduciary appearance-of-impropriety | Resolved/cleared, no charge, no sanction; weighed as appearance only per the evidentiary rule |
| M11 | Active individual equity trading while serving on sector-adjacent committees ↳ structural conflict-of-interest appearance-risk | No STOCK Act enforcement, self-dealing, or office-information-trade finding on record; raw wealth not penalized |
| M01 | No documented affirmative defense-of-the-oath-at-personal-cost stand against his own side ↳ absence of a high-mark constitutional-fidelity anchor (not misconduct) | Process record is clean; this withholds credit rather than penalizing conduct |
| M07 | Most prominent same-side break (2021 drug-pricing) coincided with heavy industry backing ↳ blunted 'at cost' purity of the active call-out duty | Genuine independent-record breaks with his party exist elsewhere |
| Pillar III | Donor-alignment (Stewardship) + active-trading structural risk (Reliability) ↳ Stewardship/Reliability drag | No exploitation finding; legal and disclosed |
| Pillar IV | Pharma-donor optics and pension-era asterisk temper the legacy (Integrity/Justice) ↳ Integrity/Justice drag | Both resolved without sanction; bipartisan institutional record offsets |
The Four Pillars, worthy to be followed?
A separate axis from the 14 measures. The measures ask did their conduct meet the standard; the Pillars ask is this someone worthy to be elevated and followed at all. The two can diverge, when they do, the divergence is the finding.
| # | Pillar | Score | Why |
|---|---|---|---|
| I | Trust & Loyalty
| 7 | why?Attributes: Steadiness, Loyalty to institution over tribe, a documented willingness to vote against his own party and a sustained bipartisan-coalition posture (Problem Solvers, New Democrats). No drag toward Collapse or Cowardice; held below the apex by the absence of a sacrifice-level oath stand. |
| II | Aspiration & Integrity
| 6 | why?Attributes: Conviction, Authenticity, a coherent, openly moderate identity he does not hide. Held at the middle by the donor-alignment optics on drug pricing, where Conviction and Self-Interest appearance are hard to disentangle. |
| III | Protection & Influence
| 6 | why?Attributes: Stewardship, Accountability, uses power within regular order, no exploitation finding. The real drag is toward Favoritism's appearance: top-of-House pharma money tracking a decisive industry-aligned vote, plus active personal trading. Optics, not a proven abuse. |
| IV | Legacy & Virtue
| 6 | why?Attributes: Integrity, institutional fidelity in a polarized era. The pension-era 'negligent' finding (cleared of fraud) and the pharma-donor asterisk are real drags toward Favoritism that temper a otherwise-respectable bipartisan legacy. |
| TOTAL: Moderate | 25/40 |
Total 25/40, Adequate-to-Sound. The bipartisan-institutional pillars hold the record up; the fiduciary and donor-alignment optics are the consistent, honestly-counted drag.
What the Four Pillars are & the questions behind each →
In their own words
“I'm proud of my independent record.”
On being ranked among House members most likely to vote against his own party · Wikipedia / press record · PRINCIPLED · cite
“Climate change is a global emergency and imminent threat that requires us to work across party lines to take bold, immediate action.”
On bipartisan climate legislation as New Democrat climate working group chair · New Democrat Coalition · CIVIC · cite
“Pharmaceutical PACs and employees were his second-largest career donor industry; he led 2021 opposition to broad Medicare drug-price negotiation.”
OpenSecrets industry totals and the 29-29 Energy & Commerce drug-pricing vote, a documented donor-alignment appearance-concern · OpenSecrets · CONTESTED · cite
Full personnel file
1. Identity
Scott Harvey Peters (born June 17, 1958). U.S. Representative from California, CA-52 2013-2023, CA-50 since 2023 (district renumbered). Democrat. Born in Springfield, Ohio, raised in Michigan. Duke University (1980), J.D. New York University (1984). EPA economist, then environmental lawyer ~15 years. San Diego City Council 2000-2008 (first council president, 2006-2008); San Diego Unified Port District commissioner/chairman 2009-2012. Moderate; vice-chair of the New Democrat Coalition; member of the Problem Solvers Caucus.
2. Voting / Legislative Profile
Voteview DW-NOMINATE center-left, consistent with his self-described moderate identity. Bipartisan signals are genuine: Problem Solvers Caucus, New Democrat Coalition vice-chair, and a 2016 ranking among House members most likely to break with their own party. Policy focus on energy, climate, and health as a member of the Energy & Commerce Committee. The 2021 vote against broad Medicare drug-price negotiation is recorded here only as a donor-alignment conduct/optics matter, NOT graded on policy merits, per the framework's refusal to score contested policy in either direction.
3. Constitutional Moments
No documented process-subversion conduct. As a Democrat seated in 2013, he is not a Texas v. Pennsylvania amicus signatory and has no fake-elector, election-overturn, or certification-subversion record. He has exercised independence by breaking with his own party's majority on multiple votes, institutional-fidelity conduct, scored as such and not on policy.
4. Rhetoric & Discourse Profile
Measured, technocratic public rhetoric matching his moderate brand. No documented dehumanizing, inciting, or enemy-making pattern. No standout high-mark civility anchor either; the rhetoric record is clean and unremarkable.
5. Fiduciary Profile
Two weighed appearance-concerns, neither a finding. Pre-Congress, the San Diego pension underfunding era: the 2006 Kroll Report labeled the council 'negligent,' but the SEC cleared the members of fraud, resolved, no charge against Peters, weighed as appearance only. In office, the clearest drag: pharmaceutical PACs are a top-two career donor industry (leading all House members in the 2022 cycle), tracking his decisive 2021 vote against broad Medicare drug-price negotiation. He is also an active individual equity trader, a standing structural conflict-of-interest appearance-risk, though no STOCK Act enforcement or self-dealing finding is on record. Legal and disclosed throughout; scored as optics, not as proven enrichment.
6. Severity-Class Conduct
No documented Severity-class conduct under any of the eight criteria. No process subversion (no Texas v. PA amicus, no election-overturn conduct), no sustained enemy-making or incitement pattern. The fiduciary appearance-concerns are real but non-criminal, resolved or uncharged. Flag count: zero.
7. What The Framework Says
Scott Peters is a clean-conduct moderate whose record is held up by a genuine bipartisan-institutional posture, Problem Solvers, New Democrats, a documented willingness to cross his own party, and held down by a consistent fiduciary-optics drag: leading the House in pharmaceutical money while casting a decisive industry-aligned drug-pricing vote, an active personal-trading footprint, and a pre-Congress 'negligent' pension-era finding (cleared of fraud). None of it is a finding of misconduct; all of it is honestly counted as appearance-concern. The result is a sound-but-asterisked record: institutionally respectable, fiduciarily watched.
8. Sources & Where To Look Deeper
Tier 1 (primary): Congress.gov member profile · House financial disclosures / Clerk of the House
Tier 2: OpenSecrets · Voteview · Ballotpedia
Research links: Congress.gov member profile · Ballotpedia · Voteview / DW-NOMINATE · OpenSecrets profile · Wikipedia
Scores derive from the fixed Constitutional Weight Schedule. The bar does not move. Conduct, not party.